Allergies & Asthma

earn free cme credit Earn CME credit by reading this article and completing the posttest. Sign Up Study Authors: Cornelia A. Verberkt, Marieke H.J. van den Beuken-van Everdingen, et al.; Eric W. Widera Target Audience and Goal Statement: Pulmonologists, pain management specialists, primary care physicians, public health and policy experts The goal of this study
0 Comments
Allergy symptoms in the eyes – they’re not something to scratch at. Called allergic conjunctivitis, some allergy sufferers experience a variety of symptoms in their eyes during allergy season. For those with indoor allergies, allergic conjunctivitis can stick around all year. Learn more about eye allergy symptoms and ways to prevent the itch and irritation
0 Comments
Fixed-dose triple therapy with fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta) improved lung function in adults whose asthma was uncontrolled with an inhaled corticosteroid (ICS) and long-acting beta-agonist (LABA), the CAPTAIN study showed. On Wednesday, based on findings from the trial, the FDA approved the chronic obstructive pulmonary disease treatment at two different doses for adults 18 and
0 Comments
Specific genetic alterations in children and teens with asthma may identify those who will not benefit from treatment with the long-acting β2-adrenergic receptor agonist (LABA) salmeterol, a researcher reported. For the study, 241 children and teens (age 12-18) with asthma taking inhaled corticosteroids were randomly assigned (1:1) to receive personalized care (prescribing by rs1042713 genotype)
0 Comments
Vitamin D3 supplementation added to low-dose inhaled corticosteroids was not associated with longer time to asthma exacerbations among high-risk children with low baseline 25-hydroxyvitamin D levels, researchers reported. The mean time to exacerbation was 240 days in children randomized to the vitamin D3 supplementation group and 253 days in the placebo group (mean group difference
0 Comments
Short-term treatment with a low-dose opioid was associated with significantly improved health status in chronic obstructive pulmonary disease (COPD) patients with advanced disease and chronic breathlessness despite optimal pharmaceutical and non-pharmaceutical treatment. In a randomized trial of over 100 patients, twice daily treatment for 4 weeks with an oral sustained-release morphine (10 mg) was associated
0 Comments
Choosing a college or university to attend for ‘the best years of your life’ can seem overwhelming and intimidating. Moving far from family and living with strangers in a completely new environment can be especially daunting when paired with a severe food allergy. In this blog, find tips to help navigate visiting and deciding on
0 Comments
As another so-called triple therapy for chronic obstructive pulmonary disease (COPD) hits the market, pulmonologists and primary care physicians are beginning to consider which patients are most appropriate for these treatments, and how much added benefit these products offer relative to more conventional — and better understood — two-drug combinations. The FDA approved AstraZeneca’s fixed-dose,
0 Comments
Throughout the spring, summer, and fall, your favorite weather source may share pollen counts for your area. These counts are used as a warning for those with environmental allergies – explaining what’s in the air and the level of symptoms you can expect. Without a little research, these pollen counts can seem confusing, but it
0 Comments
Inhaled triple therapy with budesonide, glycopyrrolate, and formoterol showed a signal of reducing all-cause mortality in patients with moderate to severe chronic obstructive pulmonary disease (COPD) at higher (320 μg) budesonide doses in newly reported findings from the large, multicenter, 52-week ETHOS trial. Two doses of the glucocorticoid — 160 μg and 320 μg —
0 Comments
The development of a subtype of inflammatory myopathy characterized by interstitial lung disease and positivity for a specific autoantibody was influenced by seasonality and place of residence, Japanese researchers found. Among patients with polymyositis or dermatomyositis (PM/DM) and the associated interstitial lung disease, symptom onset occurred most often from October to March for those with
0 Comments
earn free cme credit Earn CME credit by reading this article and completing the posttest. Sign Up Study Authors: Peter K. Lindenauer, Mihaela S. Stefan, et al.; Carolyn L. Rochester, Anne E. Holland Target Audience and Goal Statement: Pulmonologists, hospitalists The goal of this study was to determine the association between initiation of pulmonary rehabilitation
0 Comments
Cancer, diabetes, heart disease and musculoskeletal issues are often the conditions employers are most eager to tackle, and we don’t blame them – these are conditions that cost employers billions of dollars year after year. But many times, employers crunch the numbers, come up with preventive measures, and they’re still not seeing the decrease in
0 Comments
If you, like the Skeptical Cardiologist, suffer from asthma you may be wondering if you are at a higher risk of contracting COVID-19 or developing more severe respiratory complications from the disease once infected. There are 25 million asthma sufferers in the United States, about 8% of the population, and many of us are using
0 Comments